This webinar is sponsored by:
The opportunities offered by EIS is now attracting some very exciting new entrants. Companies with proven expertise and a truly global outlook.
We have invited three companies that have a tremendous track in investing in small growing companies to talk about their experience and why they are now offering these funds in the adviser market for the first time. We think they are a very welcome addition to this sector, and ideally positioned to capitalise on the post Brexit world.
Founder and CEO of Haatch VenturesView presenter info
Scott is best-known for founding one of Britain's largest e-commerce businesses Kiddicare.com which was subsequently acquired in cash for £70m, by Morrisons, one of the UK's largest supermarkets. Reaching 6th on the Retail-Week Power List, Scott is regarded by many as one of the UK's most innovative business professionals in retail. After the Kiddicare acquisition, Scott became Managing Director and Chief Architect for Morrisons.com and has a wealth of experience in building and scaling large e-commerce businesses across the UK, most notably Kiddicare.com.
Founding Haatch, Scott has invested in, and developed businesses in the areas of ad tech, B2B SaaS (software as a service) and retail tech within the FMCG market including Elevaate, founded in 2014, enabling supplier monetisation programs across retailer websites. Elevaate was acquired by Quotient Technology Inc. (NYSE: QUOT) based in Mountain View, California in October 2018, 4 years after investment from Haatch.
02h Ventures CEO and Co FounderView presenter info
Sunil Shah is a serial entrepreneur having begun his career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector. The second of these companies, Oxygen Healthcare Ltd was acquired by Piramal Enterprises Ltd (BSE: PEL). Sunil co-founded o2h Ventures which involves discovery services / collaborations, seeding drug discovery, academic in-licensing and biotechnology incubation. Sunil has a degree in Biochemistry and an MBA from Cambridge University.
Sunil is the CEO of the o2h Group. The o2h Group has developed an engine for seeding a pipeline of early stage life science assets through research collaborations, in-licensing, spin-outs & investments. The DNA of o2h is centred around the nurturing of its people, values and culture, it reflects in the way we work with each other, as well as our collaborators and partners.
Sunil has won UKBAA Angel Investor of the year 2019 Award as well as the OBN Special Recognition Award for his signification contribution in the Life Sciences Industry, he is a Board Director of Cambridge Angels and also is a member of the Advisory Panel of Cancer Research UK (CRUK) which is the UK’s largest cancer research charity. Most recently, he was also appointed as a non-executive director in the Board of BIA (BioIndustry Association Ltd). He is either Chairman, Director, Board Observer or investor of: Phoremost, Exonate, Opal Oncology, Five Alarm Bio, Somaserve, DeepMatter, Oppilotech, Sentinel, Small Pharma, Arecor, Metrion, Talisman, Stemnovate, Acacia, Privitar and Oxford Drug Design.
Nova Growth CapitalView presenter info
Andyis a software engineer and serial technology entrepreneur. Over the last 20 years he has cofounded numerous technology companies, he still holds directorships in many of them, including Lucid Games and Sentric Music. Along with software engineering.Andyhas strong financial experience, raising over £5M in seed venture capital for the companies he has co-founded. In 2017Andywas recognised by the Sunday Times as one of the UK's top 100 disruptive entrepreneurs.